Dublin, Nov. 05, 2018 (GLOBE NEWSWIRE) -- The "Global Blood Plasma Market - Analysis By Type (Immunoglobulins - IV+SC, Albumin, Factor VIII - Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)" report has been added to ResearchAndMarkets.com's offering.
The global blood plasma market is projected to display a robust growth represented by a CAGR of 10.18% during 2018 - 2023.
The Blood Plasma market witness a substantial growth at a noteworthy rate over the past few years and anticipated to grow on the back of its increasing usage in plasma-derived medical products. In addition, rise in awareness towards plasma donation, rise of China blood plasma industry, introduction of new and specialized products, rising geriatric population, rapid increase of the healthcare expenditure on the diseases such as immunodeficiency, neurological disorders, clotting disabilities etc. anticipated to boost the market growth in future.
Amongst the regions, North America accounts for the largest regional share in the global blood plasma market. Key factor driving the robust growth rate in North America region is collection of source plasma in large volume for the fractionation process.
The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global blood ingredients market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Blood Plasma Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
- Blood Plasma Market - Size, Growth, Forecast
- Analysis By Type- Size, Volume, Growth, Forecast
- Immunoglobulin (IV+SC)
- Albumin
- Factor VIII (Plasma Derived)
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Global Blood Plasma Market: Product Outlook
5. Global Blood Plasma Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
5.3 By Company Share (2017)
6. Global Blood Plasma Market Size, By Type: Breakdown (%)
6.1 Global Immunoglobulins (IV+SC) Market
6.1.1 By Value (2013-2023)
6.1.2 By Volume (2013-2023)
6.1.3 By Company Share, 2017
6.2 Global Albumin Market
6.2.1By Value (2013-2023)
6.2.2 By Volume (2013-2023)
6.2.3 By Company Share, 2017
6.3 Global FVIII (pd) Market
6.3.1 By Value (2013-2023)
6.3.2 By Volume (2013-2023)
6.3.3 By Company Share, 2017
6.4 Global Other Plasma Product Market: By Value (2013-2023)
6.5 Global Blood Plasma Market: Market Comparison, By Segments
6.6 Global Blood Plasma Market: Market Attractiveness, By Segments
7. Global Blood Plasma Market: Regional Analysis
7.1 North America Blood Plasma Market: An Analysis
7.1.1 By Value (2013-2017)
7.1.2 By Value (2018-2023)
7.2 North America Blood Plasma Market: Country Analysis
7.2.1 U.S.A Blood Plasma Market, By Value (2013-2023)
7.2.2 Canada Blood Plasma Market, By Value (2013-2023)
7.3 Europe Blood Plasma Market: An Analysis
7.3.1 By Value (2013-2017)
7.3.2 By Value (2018-2023)
7.4 Europe Blood Plasma Market: Country Analysis
7.4.1 Germany Blood Plasma Market, By Value (2013-2023)
7.4.2 France Blood Plasma Market, By Value (2013-2023)
7.4.3 Italy Blood Plasma Market, By Value (2013-2023)
7.5 APAC Blood Plasma Market: An Analysis
7.5.1 China Blood Plasma Market, By Value (2013-2023)
7.5.2 Japan Blood Plasma Market, By Value (2013-2023)
7.5.3 India Blood Plasma Market, By Value (2013-2023)
7.5.4 Australia Blood Plasma Market, By Value (2013-2023)
7.5.5 South-East Asia Blood Plasma Market, By Value (2013-2023)
7.6 ROW Blood Plasma Market: An Analysis
7.6.1 By Value (2013-2017)
7.6.2 By Value (2013-2023)
7.7 Global Blood Plasma Market: Market Comparison, By Regions
7.8 Global Blood Plasma Market: Market Attractiveness, By Regions
8. Global Blood Plasma Market Dynamics
8.1 Drivers
8.2 Challenges
8.3 Trends
9. Blood Plasma Market: Policy and Regulatory Landscape
10. Global Blood Plasma Market: Supply Chain Analysis
11. Porter's Five Forces Analysis
12 Company Profiles
12.1 CSL Limited
12.2 Baxter International
12.3 Grifols S.A.
12.4 Octa Pharma
12.5 Emergent Bio-solutions
12.6 Antaris Pharma
12.7 AMAG Pharma
12.8 Kedrion Biota Pharma
12.9 Bio delivery Science International
12.10 Biotest A.G.
For more information about this report visit https://www.researchandmarkets.com/research/r6bqv9/global_blood?w=12
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.